U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Emerging Infectious Diseases

CDC Stacks Public Health Publications

Emerging Infectious Diseases (EID) is a peer-reviewed, monthly journal published by the Centers for Disease Control and Prevention (CDC). It offers the latest scientific information on emerging infectious diseases and trends. Emerging Infectious Diseases is freely available to the public as Diamond Open Access. For more on EID, visit https://wwwnc.cdc.gov/eid.

(2)
(1)
(298)
(338)
(552)
(470)
(665)
(520)
(522)
(529)
(508)
(549)
(530)
(503)
(519)
(590)
(545)
(575)
(554)
(510)
(513)
(499)
(522)
(375)
(338)
(248)
(132)
(184)
(149)
(95)
(82)
(52)
0 of 32
(1)
(11265)
(4)
(938)
(484)
0 of 5
(13)
(93)
(6)
(7)
(4)
(7)
(46)
(22)
(8)
(24)
(2)
(11)
(1)
(15)
(1)
(3)
(17)
(17)
(1)
(1)
(3)
(3)
(17)
(52)
(39)
(11)
(3)
(65)
(3)
(21)
(2)
(7)
(4)
(1)
(178)
(27)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(77)
(1)
(1)
(2)
(42)
(1)
(26)
(1)
(5)
(1)
(23)
(3)
(1)
(4)
(14)
(1)
(1)
(322)
(2)
(30)
(1)
(1)
(1)
(1)
(8)
(19)
(4)
(1)
(134)
(1)
(1)
(51)
(43)
(129)
(1)
(3)
(16)
(22)
(8)
(10)
(15)
(1)
(1)
(48)
(566)
(1)
(40)
(30)
(1)
(8)
(12)
(23)
(1)
(10)
(5)
(1)
(5)
(14)
(1)
(15)
(1)
(11)
(1)
(1)
(1)
(3)
(2)
(64)
(39)
(1)
(1)
(2)
(1)
(11)
(5)
(2)
(14)
(1)
(13)
(38)
(1)
(1)
(61)
(5)
(1)
(5)
(1)
(39)
(1)
(261)
(5)
(13)
(5)
(5)
(56)
(1)
(50)
(285)
(27)
(27)
(3)
(46)
(19)
(1)
(234)
(1)
(1)
(1)
(38)
(22)
(46)
(2)
(6)
(1)
(5)
(15)
(36)
(2)
(4)
(59)
(12)
(1)
(4)
(89)
(17)
(3)
(8)
(1)
(26)
(188)
(7)
(1)
(6)
(1)
(6)
(45)
(11)
(25)
(10)
(7)
(75)
(109)
(10)
(230)
(8)
(8)
(1)
(13)
(7)
(92)
(4)
(2)
(2)
(1)
(1)
(7)
(3)
(21)
(16)
(2)
(5)
(3)
(26)
(2)
(2)
(10)
(2)
(1)
(8)
(15)
(1)
(4)
(2)
(35)
(1)
(7)
(33)
(28)
(1)
(13)
(1)
(1)
(1)
(7)
(2)
(30)
(26)
(12)
(5)
(5)
(2)
(4)
(1)
(1)
(96)
(2)
(24)
(1)
(8)
(1)
(18)
(7)
(1)
(1)
(40)
(7)
(16)
(1)
(16)
(12)
(19)
(12)
(34)
(7)
(4)
(17)
(128)
(3)
(2)
(5)
(15)
(2)
(1)
(4)
(21)
(16)
(1)
(2)
(17)
(1)
(69)
(1)
(1)
(7)
(70)
(47)
(10)
(7)
(57)
(1)
(59)
(23)
(3)
(1)
(3)
(1)
(1)
(9)
(13)
(5)
(1)
(1)
(2)
(30)
(8)
(4)
(3)
(45)
(19)
(3)
(2)
(14)
(20)
(18)
(1)
(3)
(2)
(5)
(2)
(1)
(12)
(1)
(3)
(38)
(1)
(2)
(9)
(18)
(8)
(1)
(33)
(58)
(4)
(1)
(22)
(1)
(10)
(18)
(24)
(1)
(28)
(5)
(19)
(19)
(163)
(1)
(14)
(8)
(9)
(59)
(5)
(1)
(1)
(1)
(9)
(1)
(3)
(48)
(1)
(16)
(1)
(40)
(3)
(1)
(10)
(3)
(40)
(49)
(1)
(6)
(11)
(13)
(138)
(36)
(1)
(2)
(4)
(3)
(9)
(1)
(11)
(10)
(176)
(1)
(29)
(1)
(24)
(1)
(1)
(1)
(3)
(1)
(1)
(3)
(31)
(37)
(9)
(1)
(82)
(4)
(44)
(1)
(1)
(27)
(84)
(143)
(1)
(9)
(2)
(9)
(1)
(1)
(2)
(1)
(2)
(16)
(8)
(1)
(73)
(9)
(14)
(103)
(881)
(3)
(12)
(3)
(18)
(5)
(2)
(16)
(2)
(11)
(100)
(18)
(25)
(27)
(1)
(10)
(4)
(13)
(20)
(4)
(7)
(1)
(3)
(1)
(19)
(5)
0 of 441
(53)
(82)
(95)
(151)
(190)
(133)
(249)
(336)
(377)
(528)
(500)
(513)
(510)
(554)
(575)
(523)
(591)
(515)
(499)
(532)
(545)
(505)
(528)
(519)
(521)
(629)
(506)
(551)
(338)
(298)
0 of 30
(1123)
(1151)
(1065)
(1105)
(1034)
(1034)
(977)
(942)
(967)
(933)
(946)
(1019)
0 of 12
(23)
(18)
(69)
(155)
(28)
(23)
(19)
(84)
(23)
(21)
(1569)
(2669)
(103)
(21)
(19)
(22)
(77)
(123)
(1418)
(301)
(253)
(22)
(41)
(31)
(16)
(25)
(38)
(22)
(71)
(17)
(117)
(25)
(19)
(19)
(54)
(56)
(38)
(3984)
(93)
(189)
(23)
(41)
(57)
(25)
(86)
(742)
(105)
(20)
(153)
(20)
(27)
(54)
(38)
(631)
(86)
(19)
(51)
(78)
(73)
(36)
(17)
(19)
(131)
(138)
(68)
(19)
(45)
(27)
(25)
(39)
(22)
(19)
(32)
(19)
(24)
(29)
(25)
(37)
(33)
(31)
(165)
(209)
(76)
(60)
(169)
(57)
(136)
(16)
(20)
(46)
(56)
(230)
(28)
(40)
(97)
(141)
(18)
(37)
(46)
(36)
(84)
(109)
(209)
(34)
(20)
(17)
(16)
(66)
(28)
(24)
(20)
(18)
(208)
(24)
(18)
(68)
(21)
(20)
(19)
(18)
(107)
(16)
(39)
(64)
(32)
(25)
(27)
(33)
(202)
(21)
(38)
(28)
(19)
(139)
(37)
(41)
(62)
(16)
(30)
(26)
(62)
(38)
(21)
(89)
(217)
(63)
(17)
(143)
(296)
(119)
(22)
(82)
(20)
(25)
(36)
(31)
(37)
(16)
(162)
(37)
(51)
(27)
(1519)
(1232)
(151)
(23)
(17)
(87)
(24)
(61)
(17)
(27)
(60)
(38)
(16)
(123)
(21)
(40)
(126)
(110)
(38)
(23)
(181)
(197)
(544)
(25)
(21)
(134)
(31)
(24)
(107)
(49)
(20)
(476)
(40)
(22)
(21)
(36)
(394)
(31)
(20)
(21)
(30)
(27)
(186)
(38)
(148)
(29)
(51)
(28)
(68)
(66)
(23)
(16)
(16)
(47)
(16)
(46)
(16)
(277)
(19)
(18)
(50)
(16)
(38)
(163)
(55)
(45)
(66)
(20)
(26)
(175)
(139)
(32)
(18)
(28)
(68)
(20)
(20)
(154)
(26)
(18)
(27)
(24)
(16)
(44)
(57)
(1911)
(18)
(318)
(35)
(84)
(74)
(2069)
(20)
(18)
(152)
(272)
(48)
(17)
(46)
(322)
(32)
(91)
(31)
(244)
(43)
(45)
(60)
(38)
(90)
(21)
(16)
(57)
(26)
(61)
(141)
(18)
(20)
(25)
(22)
(35)
(25)
(48)
(26)
(47)
(40)
(30)
(83)
(36)
(44)
(51)
(46)
(21)
(29)
(17)
(43)
(28)
(19)
(59)
(33)
(41)
(27)
(50)
(118)
(77)
(24)
(105)
(76)
(29)
(19)
(69)
(106)
(32)
(16)
(62)
(66)
(30)
(17)
(25)
(122)
(52)
(98)
(17)
(28)
(65)
(24)
(31)
(52)
(27)
(201)
(274)
(3339)
(33)
(81)
(28)
(29)
(33)
(27)
(22)
(55)
(25)
(54)
(34)
(191)
(35)
(23)
(112)
(24)
(39)
(99)
(19)
(20)
(31)
(16)
(36)
(168)
(16)
(17)
(25)
(16)
(168)
(157)
(228)
(100)
(208)
(77)
(530)
(86)
(83)
(180)
(38)
(71)
(32)
(20)
(55)
(50)
(31)
(18)
(18)
(22)
(31)
(75)
(29)
(17)
(18)
(46)
(155)
(63)
(16)
(29)
(20)
(66)
(97)
(45)
(21)
(20)
(26)
(47)
(19)
(38)
(58)
(24)
(25)
(57)
(126)
(43)
(23)
(17)
(16)
(40)
(91)
(63)
(25)
(21)
(52)
(18)
(16)
(16)
(16)
(28)
(27)
(83)
(77)
(253)
(160)
(16)
(18)
(132)
(23)
(44)
(32)
(84)
(121)
(229)
(53)
(23)
(17)
(8858)
(17)
(35)
(21)
(36)
(16)
(31)
(116)
(155)
(110)
(47)
(595)
(1001)
(414)
(27)
(86)
(23)
(32)
(42)
(33)
(81)
(286)
(52)
(222)
(19)
(45)
(20)
(76)
(149)
(80)
(128)
(619)
(19)
(17)
(20)
(27)
(18)
(210)
(21)
(44)
(56)
(28)
(25)
(20)
(38)
(107)
(52)
(30)
(20)
(19)
(46)
(28)
(26)
(63)
(39)
(26)
(22)
(16)
(21)
(20)
(19)
(38)
(19)
(20)
(35)
(39)
(21)
(22)
(39)
(20)
(101)
(28)
(22)
(53)
(39)
(49)
(26)
(39)
(60)
(37)
(16)
(78)
(22)
(21)
(22)
(18)
(42)
(30)
(137)
(102)
(33)
(19)
(3453)
(33)
(16)
(61)
(27)
(34)
(68)
(19)
(58)
(28)
(28)
(44)
(19)
(55)
(27)
(24)
(32)
(25)
(114)
(51)
(22)
(217)
(553)
(20)
(2114)
(79)
(75)
(16)
(29)
(65)
(36)
(33)
(57)
(154)
(536)
(132)
(47)
(50)
(19)
(50)
(30)
(33)
(51)
(170)
(58)
(19)
(156)
(77)
(17)
(57)
(86)
(112)
(91)
(20)
(56)
(53)
(36)
(22)
(19)
(55)
(47)
(60)
(16)
(66)
(28)
(54)
(116)
(24)
(17)
(24)
(93)
(38)
(87)
(25)
(31)
(21)
(21)
(30)
(17)
(19)
(19)
(41)
(153)
(25)
(120)
(58)
(18)
(22)
(45)
(40)
(412)
(39)
(17)
(36)
(23)
(56)
(21)
(17)
(18)
(22)
(20)
(26)
(21)
(150)
(22)
(19)
(19)
(25)
(51)
(17)
(37)
(1516)
(51)
(40)
(56)
(56)
(34)
(46)
(77)
(45)
(51)
(37)
(18)
(22)
(25)
(161)
(19)
(18)
(19)
(17)
(538)
(17)
(68)
(72)
(30)
(39)
(23)
(20)
(633)
(113)
(107)
(19)
(208)
(105)
(589)
(17)
(21)
(45)
(21)
(22)
(24)
(19)
(140)
(35)
(21)
(21)
(275)
(26)
(231)
(71)
(64)
(20)
(66)
(95)
(17)
(49)
(217)
(44)
(82)
(37)
(25)
(28)
(35)
(23)
(92)
(26)
(50)
(69)
(44)
(46)
(34)
(25)
(21)
(43)
(19)
(25)
(1499)
(79)
(142)
(45)
(22)
(24)
(17)
(173)
(365)
(258)
(33)
(17)
(27)
(139)
(129)
(36)
(39)
(64)
(65)
(634)
(20)
(95)
(278)
(31)
(91)
(79)
(52)
(65)
(21)
(83)
(30)
(44)
(50)
(133)
(38)
(26)
(63)
(26)
(31)
(103)
(27)
(30)
(27)
(19)
(43)
(282)
(17)
(47)
(24)
(37)
(293)
(78)
(61)
(136)
(31)
(75)
(518)
(37)
(29)
(386)
(107)
(80)
(266)
(163)
(22)
(21)
(51)
(29)
(19)
(38)
(27)
(100)
(45)
(17)
(20)
(17)
(23)
(17)
(20)
(33)
(36)
(55)
(28)
(38)
(31)
(50)
(25)
(26)
(22)
(44)
(18)
(134)
(31)
(34)
(19)
(17)
(38)
(176)
(25)
(17)
(52)
(61)
(120)
(18)
(50)
(29)
(54)
(27)
(18)
(29)
(25)
(20)
(22)
(25)
(35)
(18)
(30)
(27)
(27)
(309)
(152)
(19)
(29)
(26)
(244)
(18)
(17)
(56)
(33)
(33)
(40)
(58)
(148)
(363)
(45)
(27)
(402)
(24)
(33)
(186)
(20)
(200)
(20)
(91)
(106)
(43)
(23)
(23)
(34)
(51)
(52)
(23)
(225)
(34)
(18)
(25)
(28)
(35)
(31)
(57)
(79)
(20)
(21)
(18)
(21)
(44)
(72)
(36)
(105)
(52)
(41)
(133)
(28)
(62)
(55)
(44)
(199)
(23)
(27)
(90)
(50)
(218)
(77)
(55)
(65)
(38)
(19)
(27)
(17)
(18)
(842)
(105)
(98)
(31)
(669)
(57)
(140)
(23)
(24)
(48)
(46)
(21)
(26)
(539)
(17)
(18)
(49)
(60)
(17)
(51)
(25)
(27)
(30)
(27)
(19)
(32)
(23)
(362)
(37)
(70)
(26)
(46)
(21)
(17)
(173)
(29)
(31)
(47)
(19)
(26)
(20)
(58)
(23)
(27)
(19)
(21)
(36)
(28)
(95)
(23)
(51)
(23)
(33)
(46)
(25)
(21)
(18)
(18)
(18)
(88)
(23)
(111)
(28)
(24)
(30)
(40)
(23)
(17)
(30)
(62)
(211)
(128)
(27)
(24)
(28)
(28)
(18)
(23)
(88)
(17)
(30)
(49)
(63)
(51)
(93)
(34)
(22)
(29)
(151)
(21)
(554)
(42)
(303)
(24)
0 of 1000
(8)
(10)
(9)
(8)
(8)
(9)
(12)
(7)
(10)
(16)
(12)
(11)
(7)
(7)
(15)
(7)
(22)
(7)
(7)
(11)
(13)
(8)
(7)
(10)
(7)
(8)
(7)
(10)
(15)
(9)
(8)
(13)
(8)
(7)
(8)
(7)
(9)
(8)
(10)
(7)
(10)
(7)
(9)
(10)
(9)
(10)
(11)
(11)
(10)
(10)
(8)
(8)
(7)
(50)
(7)
(7)
(9)
(10)
(7)
(7)
(9)
(15)
(8)
(8)
(7)
(8)
(10)
(7)
(7)
(12)
(8)
(10)
(11)
(9)
(8)
(7)
(14)
(11)
(9)
(7)
(17)
(8)
(8)
(7)
(8)
(14)
(10)
(11)
(7)
(7)
(10)
(10)
(10)
(9)
(12)
(7)
(9)
(13)
(90)
(23)
(20)
(10)
(15)
(15)
(8)
(8)
(26)
(8)
(12)
(11)
(9)
(7)
(7)
(11)
(17)
(7)
(8)
(7)
(14)
(9)
(7)
(14)
(11)
(7)
(11)
(8)
(27)
(13)
(9)
(8)
(8)
(11)
(10)
(8)
(7)
(15)
(12)
(9)
(10)
(7)
(10)
(7)
(11)
(7)
(8)
(21)
(12)
(7)
(14)
(12)
(8)
(7)
(9)
(9)
(8)
(7)
(11)
(7)
(7)
(9)
(11)
(7)
(9)
(8)
(11)
(20)
(10)
(8)
(10)
(18)
(16)
(7)
(10)
(10)
(17)
(8)
(10)
(17)
(13)
(13)
(12)
(8)
(7)
(9)
(47)
(8)
(7)
(10)
(10)
(7)
(8)
(13)
(7)
(8)
(11)
(11)
(7)
(9)
(27)
(11)
(9)
(15)
(7)
(9)
(8)
(12)
(9)
(18)
(8)
(7)
(9)
(8)
(12)
(11)
(9)
(9)
(7)
(7)
(15)
(8)
(9)
(9)
(7)
(7)
(15)
(21)
(8)
(8)
(34)
(14)
(64)
(9)
(12)
(7)
(12)
(8)
(9)
(11)
(8)
(8)
(14)
(8)
(10)
(9)
(11)
(7)
(8)
(8)
(8)
(9)
(11)
(7)
(15)
(7)
(14)
(7)
(22)
(11)
(8)
(8)
(8)
(8)
(12)
(7)
(8)
(7)
(9)
(17)
(10)
(10)
(23)
(8)
(9)
(18)
(7)
(8)
(7)
(8)
(9)
(13)
(11)
(7)
(9)
(9)
(16)
(16)
(10)
(18)
(9)
(27)
(12)
(10)
(7)
(15)
(8)
(13)
(9)
(8)
(9)
(7)
(12)
(7)
(11)
(9)
(7)
(14)
(9)
(8)
(19)
(7)
(15)
(10)
(7)
(25)
(12)
(11)
(8)
(7)
(11)
(9)
(8)
(10)
(10)
(7)
(8)
(7)
(7)
(9)
(7)
(12)
(10)
(8)
(11)
(7)
(11)
(7)
(15)
(16)
(28)
(10)
(7)
(9)
(9)
(7)
(7)
(8)
(26)
(8)
(10)
(9)
(8)
(8)
(15)
(11)
(8)
(16)
(11)
(29)
(17)
(9)
(15)
(8)
(7)
(8)
(30)
(12)
(7)
(8)
(8)
(11)
(7)
(8)
(8)
(17)
(11)
(7)
(7)
(12)
(8)
(8)
(8)
(37)
(7)
(7)
(11)
(11)
(10)
(10)
(7)
(16)
(7)
(19)
(7)
(9)
(7)
(15)
(8)
(12)
(9)
(9)
(7)
(8)
(31)
(7)
(7)
(8)
(7)
(7)
(7)
(14)
(10)
(8)
(18)
(9)
(8)
(7)
(7)
(16)
(7)
(13)
(8)
(12)
(8)
(10)
(11)
(8)
(8)
(9)
(8)
(11)
(8)
(10)
(17)
(13)
(7)
(8)
(9)
(7)
(8)
(17)
(11)
(7)
(7)
(8)
(9)
(7)
(8)
(8)
(7)
(7)
(7)
(9)
(12)
(10)
(11)
(11)
(8)
(13)
(21)
(7)
(7)
(11)
(9)
(9)
(7)
(10)
(9)
(11)
(13)
(12)
(8)
(13)
(16)
(13)
(11)
(7)
(7)
(18)
(7)
(20)
(20)
(7)
(7)
(10)
(7)
(8)
(20)
(8)
(13)
(10)
(8)
(14)
(10)
(11)
(11)
(10)
(19)
(36)
(8)
(12)
(14)
(9)
(9)
(17)
(10)
(7)
(22)
(17)
(7)
(9)
(7)
(7)
(7)
(11)
(14)
(7)
(7)
(9)
(13)
(7)
(21)
(7)
(13)
(7)
(7)
(10)
(7)
(8)
(17)
(16)
(7)
(12)
(8)
(11)
(12)
(8)
(9)
(7)
(9)
(17)
(7)
(10)
(7)
(8)
(7)
(7)
(7)
(24)
(17)
(9)
(8)
(7)
(8)
(11)
(11)
(7)
(15)
(22)
(8)
(8)
(7)
(8)
(22)
(13)
(17)
(7)
(16)
(8)
(9)
(20)
(17)
(10)
(12)
(9)
(8)
(31)
(9)
(8)
(9)
(15)
(15)
(7)
(7)
(10)
(7)
(10)
(10)
(7)
(8)
(8)
(12)
(17)
(7)
(10)
(10)
(9)
(7)
(8)
(7)
(7)
(24)
(7)
(9)
(7)
(8)
(7)
(9)
(7)
(8)
(8)
(8)
(17)
(18)
(8)
(10)
(17)
(15)
(10)
(7)
(7)
(34)
(11)
(10)
(7)
(16)
(9)
(14)
(8)
(7)
(9)
(9)
(8)
(7)
(8)
(10)
(7)
(7)
(15)
(10)
(15)
(7)
(7)
(14)
(10)
(9)
(8)
(19)
(9)
(11)
(16)
(19)
(7)
(8)
(15)
(12)
(8)
(12)
(8)
(7)
(12)
(15)
(12)
(9)
(10)
(7)
(7)
(8)
(8)
(10)
(8)
(7)
(39)
(12)
(9)
(14)
(12)
(7)
(11)
(9)
(7)
(21)
(16)
(7)
(7)
(14)
(13)
(19)
(16)
(8)
(7)
(9)
(7)
(15)
(15)
(9)
(32)
(12)
(19)
(8)
(7)
(34)
(22)
(14)
(27)
(8)
(23)
(11)
(11)
(7)
(49)
(8)
(8)
(9)
(7)
(13)
(8)
(11)
(9)
(7)
(9)
(9)
(7)
(13)
(43)
(13)
(9)
(7)
(7)
(15)
(7)
(8)
(21)
(10)
(7)
(7)
(20)
(11)
(7)
(8)
(7)
(9)
(18)
(7)
(9)
(25)
(25)
(16)
(7)
(18)
(10)
(129)
(8)
(7)
(12)
(9)
(7)
(8)
(8)
(8)
(14)
(7)
(9)
(11)
(15)
(151)
(7)
(7)
(7)
(8)
(8)
(7)
(10)
(10)
(12)
(13)
(15)
(8)
(23)
(8)
(8)
(8)
(9)
(8)
(12)
(7)
(35)
(9)
(8)
(49)
(7)
(7)
(8)
(16)
(12)
(7)
(7)
(33)
(7)
(8)
(17)
(9)
(7)
(9)
(8)
(9)
(9)
(9)
(10)
(7)
(17)
(8)
(32)
(7)
(8)
(8)
(21)
(10)
(19)
(13)
(7)
(9)
(16)
(9)
(10)
(9)
(11)
(9)
(14)
(8)
(11)
(7)
(12)
(20)
(8)
(7)
(7)
(10)
(8)
(11)
(14)
(16)
(18)
(7)
(9)
(7)
(7)
(7)
(7)
(14)
(10)
(16)
(21)
(7)
(10)
(9)
(10)
(15)
(9)
(8)
(7)
(7)
(11)
(18)
(11)
(7)
(26)
(21)
(19)
(7)
(11)
(9)
(9)
(15)
(13)
(10)
(8)
(24)
(18)
(10)
(14)
(8)
(27)
(9)
(8)
(9)
(11)
(8)
(33)
(9)
(11)
(11)
(11)
(9)
(14)
(10)
(10)
(10)
(8)
(8)
(10)
(18)
(11)
(27)
(13)
(11)
(10)
(8)
(8)
(8)
(29)
(10)
(8)
(12)
(21)
(10)
(10)
(21)
(8)
(8)
(24)
(14)
(15)
(8)
(18)
(16)
(8)
(8)
(13)
(9)
(9)
(19)
(8)
(8)
(14)
(16)
(30)
(26)
(20)
(19)
(17)
(8)
(12)
(12)
(11)
(10)
(9)
(10)
(11)
(22)
(8)
(10)
(8)
(9)
(13)
(8)
(15)
(8)
(13)
(8)
(9)
(13)
(12)
(8)
(18)
(10)
(13)
(12)
(9)
(9)
(8)
(8)
(9)
(8)
(22)
(8)
(8)
(8)
(17)
(9)
(34)
(9)
(10)
(12)
(12)
(11)
(9)
(8)
(9)
(9)
(8)
(20)
(8)
(8)
(9)
(10)
(12)
(28)
(10)
(14)
(8)
0 of 1000
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(18)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
0 of 468
(126)
(1)
(5)
(2)
(6)
(61)
(1)
(1)
(1)
(3)
(25)
(1)
(291)
(1)
(2)
(43)
(4)
(1)
(3)
(1)
(240)
(6)
(431)
(1)
(1345)
(9)
(19)
(10)
(1)
(10)
(2)
(3)
(2)
(7)
(8)
(2)
(6)
(2)
(73)
(1)
(69)
(1)
(3)
(1)
(1)
(18)
(1)
0 of 47
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(3)
(1)
(6)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(11)
(33)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(2)
(1)
(6)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(46)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(72)
(3)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(10)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(10)
(3)
(1)
(18)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(8)
(5)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(2)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(16)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(4)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(13)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(4)
(2)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(15)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(5)
(2)
(1)
(1)
(4)
(3)
(7)
(1)
(1)
(15)
(1)
(4)
(1)
(1)
(15)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(71)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(3)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(8)
(5)
(1)
(7)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(7)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(11)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(4)
(1)
(1)
(2)
(1)
(2)
(2)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(44)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(3)
(1)
(1)
(3)
(3)
(1)
(3)
(2)
(4)
(5)
(1)
(1)
(1)
(6)
(2)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(6)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(8)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(5)
(2)
(2)
(4)
(2)
(2)
(54)
(23)
(66)
(2)
(2)
(4)
(2)
(2)
(2)
(2)
(4)
(3)
(7)
(8)
(2)
(3)
(5)
(2)
(2)
(3)
(8)
(2)
(3)
(2)
(2)
(3)
(4)
(4)
(2)
(5)
(2)
(5)
(82)
(2)
(3)
(2)
(4)
(3)
(2)
(2)
(2)
(2)
(4)
(2)
(10)
(3)
(4)
(2)
(5)
(2)
(2)
(54)
(2)
(3)
(5)
(5)
(6)
(2)
(2)
(2)
(9)
(3)
(5)
(177)
(3)
(2)
(7)
(2)
(2)
(2)
(2)
(6)
(8)
(2)
(2)
(3)
(2)
(3)
(2)
(8)
(3)
(2)
(4)
(2)
(3)
(2)
(6)
(2)
(4)
(4)
(26)
(47)
(3)
(4)
(2)
(6)
(3)
(2)
(2)
(3)
(2)
(3)
(2)
(6)
(2)
(2)
(8)
(2)
(3)
(2)
(2)
(2)
(2)
(2)
(3)
(7)
(3)
(20)
(2)
(26)
(4)
(4)
(2)
(2)
(16)
(2)
(2)
(3)
(19)
(2)
(3)
(5)
(2)
(2)
(25)
(3)
(2)
(3)
(4)
(2)
(2)
(2)
(3)
(4)
(3)
(2)
(2)
(5)
(2)
(6)
(46)
(2)
(2)
(3)
(2)
(2)
(4)
(2)
(2)
(5)
(3)
(5)
(2)
(2)
(2)
(33)
(29)
(5)
(2)
(2)
(2)
(2)
(3)
(2)
(2)
(6)
(2)
(2)
(3)
(2)
(6)
(5)
(3)
(4)
(16)
(2)
(2)
(2)
(7)
(2)
(6)
(19)
(4)
(5)
(18)
(2)
(4)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(19)
(4)
(2)
(4)
(38)
(2)
(2)
(5)
(3)
(3)
(5)
(3)
(2)
(7)
(5)
(2)
(3)
(3)
(2)
(5)
(5)
(2)
(43)
(25)
(5)
(3)
(2)
(2)
(2)
(2)
(2)
(111)
(2)
(2)
(4)
(2)
(3)
(2)
(25)
(3)
(3)
(2)
(2)
(3)
(2)
(7)
(53)
(2)
(20)
(2)
(2)
(4)
(4)
(15)
(5)
(2)
(2)
(3)
(2)
(3)
(15)
(2)
(6)
(3)
(5)
(10)
(14)
(7)
(5)
(3)
(18)
(14)
(58)
(3)
(2)
(209)
(2)
(2)
(12)
(2)
(3)
(4)
(2)
(3)
(3)
(156)
(2)
0 of 1000
Showing 1081 - 1100 of 12469 results
  • Mycobacterium mageritense Lymphadenitis in Child
    Mycobacterium mageritense Lymphadenitis in Child
    García-Boyano, Miguel ;
    Baquero-Artigao, Fernando
    3 2022 | Emerg Infect Dis. 2022; 28(3):752-753
    Although human infections caused by Mycobacterium mageritense are rare, there are some case reports involving sinusitis, pneumonia, and hospital-acquired infections in adults. We report a case of lymphadenitis caused by M. mageritense in a child in Spain.
    Supporting Files Public Domain
  • SARSCoV2 Breakthrough Infections after introduction of 4 COVID19 Vaccines South Korea 2021
    SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021
    Yi, Seonju ;
    Choe, Young June
    3 2022 | Emerg Infect Dis. 2022; 28(3):753-756
    We conducted a nationwide retrospective cohort study to estimate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infection among recipients of 4 different vaccines in South Korea. Age-adjusted breakthrough infection rate per month was highest for Janssen (42.6/100,000 population), followed by AstraZeneca (21.7/100,000 popu ...
    Supporting Files Public Domain
  • Overseas Treatment of Latent Tuberculosis Infection in USBound Immigrants
    Overseas Treatment of Latent Tuberculosis Infection in US–Bound Immigrants
    Khan, Amera ;
    Phares, Christina R.
    3 2022 | Emerg Infect Dis. 2022; 28(3):582-590
    Seventy percent of tuberculosis (TB) cases in the United States occur among non-US-born persons; cases usually result from reactivation of latent TB infection (LTBI) likely acquired before the person's US arrival. We conducted a prospective study among US immigrant visa applicants undergoing the required overseas medical examination in Vietnam. Con ...
    Supporting Files Public Domain
  • Rising Incidence of Legionnaires Disease and Associated Epidemiologic Patterns United States 19922018
    Rising Incidence of Legionnaires’ Disease and Associated Epidemiologic Patterns, United States, 1992–2018
    Barskey, Albert E. ;
    Derado, Gordana
    3 2022 | Emerg Infect Dis. 2022; 28(3):527-538
    Reported Legionnaires' disease (LD) cases began increasing in the United States in 2003 after relatively stable numbers for >10 years; reasons for the rise are unclear. We compared epidemiologic patterns associated with cases reported to the Centers for Disease Control and Prevention before and during the rise. The age-standardized average incidenc ...
    Supporting Files Public Domain
  • Epidemiology of COVID19 after Emergence of SARSCoV2 Gamma Variant Brazilian Amazon 20202021
    Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020–2021
    Nicolete, Vanessa C. ;
    Rodrigues, Priscila T.
    3 2022 | Emerg Infect Dis. 2022; 28(3):709-712
    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Gamma variant has been hypothesized to cause more severe illness than previous variants, especially in children. Successive SARS-CoV-2 IgG serosurveys in the Brazilian Amazon showed that age-specific attack rates and proportions of symptomatic SARS-CoV-2 infections were similar before ...
    Supporting Files
  • Relationship of SARSCoV2 Antigen and Reverse Transcription PCR Positivity for Viral Cultures
    Relationship of SARS-CoV-2 Antigen and Reverse Transcription PCR Positivity for Viral Cultures
    Currie, Dustin W. ;
    Shah, Melisa M.
    3 2022 | Emerg Infect Dis. 2022; 28(3):717-720
    We assessed the relationship between antigen and reverse transcription PCR (RT-PCR) test positivity and successful virus isolation. We found that antigen test results were more predictive of virus recovery than RT-PCR results. However, virus was isolated from some antigen-negative and RT-PCR‒positive paired specimens, providing support for the Cent ...
    Supporting Files Public Domain
  • HighDose Convalescent Plasma for Treatment of Severe COVID19
    High-Dose Convalescent Plasma for Treatment of Severe COVID-19
    De Santis, Gil C. ;
    Oliveira, Luciana Correa
    3 2022 | Emerg Infect Dis. 2022; 28(3):548-555
    To assess whether high-dose coronavirus disease (COVID-19) convalescent plasma (CCP) transfusion may benefit patients with severe COVID-19, we conducted a multicenter randomized trial in Brazil. Patients with severe COVID-19 who were within 10 days of initial symptom onset were eligible. Patients in the CCP group received 3 daily doses of CCP (600 ...
    Supporting Files Public Domain
  • Serial Intervals and Household Transmission of SARSCoV2 Omicron Variant South Korea 2021
    Serial Intervals and Household Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021
    Song, Jin Su ;
    Lee, Jihee
    3 2022 | Emerg Infect Dis. 2022; 28(3):756-759
    To clarify transmissibility of the severe acute respiratory syndrome coronavirus 2 Omicron variant, we determined serial intervals and secondary attack rates among household contacts in South Korea. Mean serial interval for 12 transmission pairs was 2.9 days, and secondary attack rate among 25 households was 50.0%, raising concern about a rapid sur ...
    Supporting Files Public Domain
  • Infection Control Measures and Prevalence of SARSCoV2 IgG among 4554 University Hospital Employees Munich Germany
    Infection Control Measures and Prevalence of SARS-CoV-2 IgG among 4,554 University Hospital Employees, Munich, Germany
    Erber, Johanna ;
    Kappler, Verena
    3 2022 | Emerg Infect Dis. 2022; 28(3):572-581
    Hospital staff are at high risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the coronavirus disease (COVID-19) pandemic. This cross-sectional study aimed to determine the prevalence of SARS-CoV-2 infection in hospital staff at the University Hospital rechts der Isar in Munich, Germany, and identify modulating f ...
    Supporting Files Public Domain
  • SARSCoV2 Period Seroprevalence and Related Factors Hillsborough County Florida USA October 2020March 2021
    SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020–March 2021
    Giuliano, Anna R. ;
    Pilon-Thomas, Shari
    3 2022 | Emerg Infect Dis. 2022; 28(3):556-563
    Estimating the actual extent of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is challenging because virus test positivity data undercount the actual number and proportion of persons infected. SARS-CoV-2 seroprevalence is a marker of past SARS-CoV-2 infection regardless of presence or severity of symptoms and therefore i ...
    Supporting Files
  • Retrospective Cohort Study of Effects of the COVID19 Pandemic on Tuberculosis Notifications Vietnam 2020
    Retrospective Cohort Study of Effects of the COVID-19 Pandemic on Tuberculosis Notifications, Vietnam, 2020
    Hasan, Tasnim ;
    Nguyen, Viet Nhung
    3 2022 | Emerg Infect Dis. 2022; 28(3):684-692
    We evaluated the effects of the coronavirus disease pandemic on diagnosis of and treatment for tuberculosis (TB) in Vietnam. We obtained quarterly notifications for TB and multidrug-resistant/rifampin-resistant (MDR/RR) TB from 2015-2020 and evaluated changes in monthly TB case notifications. We used an interrupted time series to assess the change ...
    Supporting Files Public Domain
  • Sensitivity of Mycobacterium leprae to Telacebec
    Sensitivity of Mycobacterium leprae to Telacebec
    Lahiri, Ramanuj ;
    Adams, Linda B.
    3 2022 | Emerg Infect Dis. 2022; 28(3):749-751
    The treatment of leprosy is long and complex, benefiting from the development of sterilizing, rapidly-acting drugs. Reductive evolution made Mycobacterium leprae exquisitely sensitive to Telacebec, a phase 2 drug candidate for tuberculosis| The unprecedented potency of Telacebec against M. leprae warrants further validation in clinical trials.
    Supporting Files Public Domain
  • Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level
    Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level
    Barr, Ian G. ;
    Williams, Thomas C.
    3 2022 | Emerg Infect Dis. 2022; 28(3):764
    No Description
    Supporting Files Public Domain
  • Effectiveness of 3 COVID19 Vaccines in Preventing SARSCoV2 Infections JanuaryMay 2021 Aragon Spain
    Effectiveness of 3 COVID-19 Vaccines in Preventing SARS-CoV-2 Infections, January–May 2021, Aragon, Spain
    del Cura-Bilbao, Alicia ;
    López-Mendoza, Héctor
    3 2022 | Emerg Infect Dis. 2022; 28(3):591-598
    Reducing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission is a worldwide challenge; widespread vaccination could be one strategy for control. We conducted a prospective, population-based cohort study of 964,258 residents of Aragon, Spain, during December 2020-May 2021. We used the Cox proportional-hazards model with vaccina ...
    Supporting Files Public Domain
  • Airborne Transmission of SARSCoV2 Delta Variant within Tightly Monitored Isolation Facility New Zealand Aotearoa
    Airborne Transmission of SARS-CoV-2 Delta Variant within Tightly Monitored Isolation Facility, New Zealand (Aotearoa)
    Fox-Lewis, Andrew ;
    Williamson, Felicity
    3 2022 | Emerg Infect Dis. 2022; 28(3):501-509
    In New Zealand, international arrivals are quarantined and undergo severe acute respiratory syndrome coronavirus 2 screening; those who test positive are transferred to a managed isolation facility (MIF). Solo traveler A and person E from a 5-person travel group (BCDEF) tested positive. After transfer to the MIF, person A and group BCDEF occupied r ...
    Supporting Files Public Domain
  • Disseminated Histoplasmosis in Persons with HIVAIDS Southern Brazil 20102019
    Disseminated Histoplasmosis in Persons with HIV/AIDS, Southern Brazil, 2010–2019
    Basso, Rossana Patricia ;
    Poester, Vanice Rodrigues
    3 2022 | Emerg Infect Dis. 2022; 28(3):721-724
    We evaluated disseminated histoplasmosis (DH) in HIV patients over 10 years in southern Brazil. The incidence was 12 cases/1,000 hospitalizations (2010-2019); the mortality rate was 35%. Tuberculosis frequently obscured the diagnosis of DH. We emphasize the need in our region to suspect and investigate DH using more sensitive methods.
    Supporting Files Public Domain
  • Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola Sierra Leone
    Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone
    Manno, Daniela ;
    Ayieko, Philip
    3 2022 | Emerg Infect Dis. 2022; 28(3):734-738
    We explored the association of Ebola virus antibody seropositivity and concentration with potential risk factors for infection. Among 1,282 adults and children from a community affected by the 2014-2016 Ebola outbreak in Sierra Leone, 8% were seropositive for virus antibodies but never experienced disease symptoms. Antibody concentration increased ...
    Supporting Files Public Domain
  • Effects of COVID19 Pandemic Response on Service Provision for Sexually Transmitted Infections HIV and Viral Hepatitis England
    Effects of COVID-19 Pandemic Response on Service Provision for Sexually Transmitted Infections, HIV, and Viral Hepatitis, England
    Mitchell, Holly D. ;
    Vilaplana, Tatiana Garcia
    3 2022 | Emerg Infect Dis. 2022; 28(3):739-742
    Since the coronavirus disease pandemic response began in March 2020, tests, vaccinations, diagnoses, and treatment initiations for sexual health, HIV, and viral hepatitis in England have declined. The shift towards online and outreach services happened rapidly during 2020 and highlights the need to evaluate the effects of these strategies on health ...
    Supporting Files Public Domain
  • Return of Norovirus and Rotavirus Activity in Winter 202021 in City with Strict COVID19 Control Strategy China
    Return of Norovirus and Rotavirus Activity in Winter 2020‒21 in City with Strict COVID-19 Control Strategy, China
    Chan, Martin Chi-Wai
    3 2022 | Emerging Infectious Diseases
    A rapid decrease in viral gastroenteritis during winter 2019-20 and a return of norovirus and rotavirus activity during winter 2020-21 were observed while multiple nonpharmaceutical interventions for coronavirus disease were in effect in Hong Kong. The initial collateral benefit of coronavirus disease countermeasures that reduced the viral gastroen ...
    Supporting Files Public Domain
  • Plasmodium falciparum pfhrp2 and pfhrp3 Gene Deletions from Persons with Symptomatic Malaria Infection in Ethiopia Kenya Madagascar and Rwanda
    Plasmodium falciparum pfhrp2 and pfhrp3 Gene Deletions from Persons with Symptomatic Malaria Infection in Ethiopia, Kenya, Madagascar, and Rwanda
    Rogier, Eric ;
    McCaffery, Jessica N.
    2022/03/01 | Emerg Infect Dis. 2022; 28(3):608-616
    Histidine-rich protein 2 (HRP2)-based rapid diagnostic tests detect Plasmodium falciparum malaria and are used throughout sub-Saharan Africa. However, deletions in the pfhrp2 and related pfhrp3 (pfhrp2/3) genes threaten use of these tests. Therapeutic efficacy studies (TESs) enroll persons with symptomatic P. falciparum infection. We screened TES s ...
    Supporting Files Public Domain
1081 - 1100 / 12469
 Was this page helpful?
 Found an issue?
Send us an email at: publishinghd@cdc.gov